🏙️ Alpha-9 Theranostics announces oversubscribed $75M Series B

Plus, seven other stories you may have missed.

Happy Thursday. Welcome to the Morning Report. If someone else sent you this, you can subscribe right here, right now:

Alpha-9 Theranostics, a biotech company developing radiopharmaceuticals with the potential to improve the treatment of people living with cancer, announced an oversubscribed $75 million Series B round. The round was led by Nextech Invest…